Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

AntiCancer's HDRA receives patent protection

April 26, 1996

Athena receives patent protection for ApoE in diagnosis of AD

April 26, 1996

Neoprobe, Peptor to codevelop peptide analogues for cancer diagnosis & treatment

April 26, 1996

Tosoh, Morinaga Milk claim type IV collagen detection system

April 26, 1996

Sero-Strip HIV-1/2 shows 100% efficacy in Swedish study

April 19, 1996

Amersham reaches licensing agreement for Ceretec

April 12, 1996

AltaRex, Resolution to codevelop cancer diagnostics

April 12, 1996

PP-14 gives positive interim clinical results

April 12, 1996

Abbott has option to license TB diagnostic from Inflazyme

April 12, 1996

Sero-Strip HIV-1/2 efficacy demonstrated at CDC

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 5, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Associate degree: PTC’s hints of phase II HD efficacy studied
BioWorld
PTC Therapeutics Inc. CEO Matthew Klein said the firm “achieved all we set out to [achieve] in phase II” with PTC-518 in Huntington’s disease (HD), but it wasn’t...